MedTrace Logo

ERIGO® Life- Control of Cardiovascular Parameters Via Verticalization and Simultaneous Mobilization

NCT02268266 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2015-11-18

No results posted yet for this study

Summary

Early verticalization and stepping with the equipment of Hocoma ERIGO during monitoring of vital parameters. The device is already CE marked and, for the purposes of the study, will be used in accordance with the intended use (after-market clinical investigation).

Conditions

Interventions

DEVICE

Erigo

The control of cardiovascular parameters within suitable ranges for healthy and neurological patients using verticalization, leg mobilization and electrical stimulation

Sponsors & Collaborators

  • Zuercher Hoehenklinik Wald

    collaborator OTHER

  • Hocoma AG, Switzerland

    collaborator UNKNOWN

  • Swiss Federal Institute of Technology

    lead OTHER

Principal Investigators

  • Robert Riener, Prof.Dr.-Ing · Swiss Federal Institut of Technology

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2010-04-30
Primary Completion
2015-03-31
Completion
2015-03-31

Countries

  • Switzerland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02268266 on ClinicalTrials.gov